Analysis of the differential modulation of sulphonylurea block of β-cell and cardiac ATP-sensitive K+ (KATP) channels by Mg-nucleotides

Journal of Physiology

Volumn 547, Issue 1, 2003, Pages 159-168

  Reimann, Frank ^a,b   Dabrowski, Michael ^a   Jones, Phillippa ^a   Gribble, Fiona M ^b   Ashcroft, Frances M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLICLAZIDE; MAGNESIUM; MEGLITINIDE; NUCLEOTIDE; POTASSIUM CHANNEL; RECEPTOR SUBUNIT; SULFONYLUREA; SULFONYLUREA RECEPTOR; TOLBUTAMIDE; ADENOSINE DIPHOSPHATE MAGNESIUM; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR 1; SULFONYLUREA RECEPTOR 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; BINDING AFFINITY; CHIMERA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; METABOLIC INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PANCREAS ISLET BETA CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; XENOPUS; ARTICLE; HETEROLOGOUS EXPRESSION; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BENZAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPOGLYCEMIC AGENTS; ION CHANNEL GATING; ISLETS OF LANGERHANS; MICE; MUTAGENESIS; MYOCARDIUM; OOCYTES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RECEPTORS, DRUG; RECOMBINANT FUSION PROTEINS; TOLBUTAMIDE; XENOPUS LAEVIS;

EID: 0037440756     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.031625     Document Type: Review

References (46)

1. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AE III, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J & Nelson DA (1995). Cloning of the beta-cell high-affinity sulphonylurea receptor: a regulator of insulin secretion. Science 268, 423-425.
2. + channels: basis for channel opening behaviour. J Gen Physiol 111, 381-394.
3. + channels and insulin secretion; their role in health and disease. Diabetologia 42, 903-919.
4. Ashcroft FM & Rorsman P (1989). Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54, 87-143.
5. ATP channel. Diabetes 48, 1341-1347.
6. Babenko AP, Gonzalez G & Bryan J (2000). Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers. J Biol Chem 275, 717-720.
7. ATP channels of mammalian skeletal muscle. J Membr Biol 155, 257-262.
8. + channels toward sulfonylureas. Circ Res 82, 272-278.
9. Colquhoun D (1998). Binding, gating and efficacy. Br J Pharmacol 125, 923-947.
10. Dabrowski M, Ashcroft FM, Ashfield R, Lebrun P, Pirotte B, Egebjerg J, Hansen JB & Wahl P (2002). The novel diazoxide analogue, 3-isopropylamino-7-methoxy-4H-1,2-benzothiadiazine 1,1-dioxide, is a selective SUR1/Kir6.2 channel opener. Diabetes 51, 1896-1906.
11. Dabrowski M, Wahl P, Holmes WE & Ashcroft FM (2001). Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channel. Diabetologia 44, 747-756.
12. D'hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A & Vivaudou M (1999). Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A 96, 12162-12167.
13. Dörschner H, Brekardin E, Uhde I, Schwanstecher C & Schwanstecher M (1999). Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol Pharmacol 55, 1060-1066.
14. + channels during metabolic stress in cardiac muscle. J Pharmacol Exp Ther 266, 456-467.
15. + channel in rat pancreatic B-cells. Am J Physiol 257, C1119-1127.
16. Gribble F & Ashcroft FM (2000). New windows on the mechanism of action of potassium channel openers. Trends Pharmacol Sci 21, 439-445.
17. Gribble FM, Reimann F, Ashfield R & Ashcroft FM (2000). Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/SUR2A. Mol Pharmacol 57, 1256-1261.
18. Gribble FM, Tucker SJ & Ashcroft FM (1997a). The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J 16, 1145-1152.
19. Gribble FM, Tucker SJ & Ashcroft FM (1997b). The interaction of nucleotides with the tolbutamide block of K-ATP currents: a reinterpretation. J Physiol 504, 35-45.
20. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A 95, 7185-7190.
21. ATP channels. Diabetes 47, 1412-1418.
22. Hambrock A, Löffler-Walz C & Quast U (2002). Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides. Br J Pharmacol 136, 995-1004.
23. ATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270, 1166-1169.
24. + channels. Neuron 16, 1011-1017.
25. Inagaki N, Tsuura Y, Namba N, Masuda K, Gonoi T, Seino Y, Mizuta M & Seino S (1995b). Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 270, 5691-5694.
26. + channel. J Biol Chem 271, 24321-24325.
27. ATP channels. Functional coupling of Kir6.2 and SUR1 subunits. J Gen Physiol 114, 203-213.
28. + channel openers, and ATP. Mol Pharmacol 59, 1086-1093.
29. ATP channels in mouse isolated pancreatic β-cells but not rat heart or arterial smooth muscle cells. Diabetologia 44, 1019-1025.
30. Löffler-Walz C, Hambrock A & Quast U (2002). Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits. Mol Pharmacol 61, 407-414.
31. ATP channel. FEBS Lett 499, 154-160.
32. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP IV, Gonzalez G, Aguilar-Bryan L, Permutt MA & Bryan J (1996). Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272, 1785-1787.
33. Proks P, Reimann F, Greene N, Gribble FM & Ashcroft FM (2002). Sulphonylurea stimulation of insulin secretion. Diabetes 51, S368-S376.
34. ATP channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil. Mol Pharmacol 58, 1318-1325.
35. Reimann F, Proks P & Ashcroft FM (2001). Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. Br J Pharmacol 132, 1542-1548.
36. Reimann F, Tucker SJ, Proks P & Ashcroft FM (1999). Involvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptor. J Physiol 518, 325-336.
37. Sakura H, Ämmälä C, Smith PA, Gribble FM & Ashcroft FM (1995). Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 377, 338-344.
38. Schwanstecher M, Schwanstecher C, Chudziak F, Panten U, Clement JP IV, Gonzalez G, Aguilar-Bryan L & Bryan J (1999). ATP-sensitive potassium channels. Meth Enzymol 294, 445-458.
39. + channel with an ABC transporter. Neuron 26, 155-167.
40. ATP channel complex. J Gen Physiol 110, 655-664.
41. + channel by 8-azido-ATP. J Biol Chem 274, 3931-3933.
42. Trapp S, Proks P, Tucker SJ & Ashcroft FM (1998). Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. J Gen Physiol 112, 333-349.
43. Tucker SJ, Gribble FM, Zhao C, Trapp S & Ashcroft FM (1997). Truncation of Kir6.2 produces ATP-sensitive K-channels in the absence of the sulphonylurea receptor. Nature 387, 179-181.
44. Ueda K, Komine J, Matsuo M, Seino S & Amachi T (1999). Cooperative binding of ATP and MgADP in the sulphonylurea receptor is modulated by glibenclamide. Proc Natl Acad Sci U S A 96, 1268-1272.
45. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res 69, 623-637.
46. + channels from pancreatic β-cells. FEBS Lett 239, 241-244.